论文部分内容阅读
目的 :探讨用美托洛尔缓释片和麝香保心丸治疗冠心病不稳定型心绞痛的临床效果。方法 :对我院收治的60名冠心病不稳定型心绞痛患者的临床资料进行回顾性研究。将这60例患者分为常规治疗组和联合治疗组,每组各有30例患者。对两组患者均进行常规治疗,在此基础上,为联合治疗组患者使用美托洛尔缓释片和麝香保心丸进行治疗。然后,比较两组患者心绞痛发作的频率、心绞痛发作持续的时间和心绞痛发作间隔的时间。结果 :经过治疗,联合治疗组患者心绞痛发作的频率、心绞痛发作持续的时间、心绞痛发作间隔的时间均明显优于常规治疗组患者,差异具有统计学意义(P<0.05)。结论 :用美托洛尔缓释片和麝香保心丸治疗冠心病不稳定型心绞痛的效果显著,可有效地减少患者心绞痛发作的频率,并缩短其心绞痛发作持续的时间。
Objective: To investigate the clinical effects of metoprolol extended release tablets and musk heart-protecting pill in the treatment of unstable angina pectoris. Methods: The clinical data of 60 patients with unstable angina pectoris who were admitted to our hospital were retrospectively studied. The 60 patients were divided into the conventional treatment group and the combination treatment group, each with 30 patients. Both groups were routinely treated. On this basis, metoprolol sustained-release tablets and Shexiang Baoxin Pills were used for the treatment of patients in the combined treatment group. Then, the frequency of angina attacks, the duration of angina attacks, and the duration of angina pectoris episodes were compared between the two groups. Results: After treatment, the incidence of angina pectoris, the duration of angina pectoris and the duration of angina pectoris in the combination therapy group were significantly better than those in the conventional therapy group (P <0.05). Conclusion: Metoprolol sustained-release tablets and musk heart pills in treatment of unstable angina pectoris have a significant effect, which can effectively reduce the frequency of patients with angina pectoris and shorten the duration of angina pectoris.